Biosimilars in the U.S. and Abroad

Paul Calvo, a director at the intellectual property law firm Sterne, Kessler, Goldstein & Fox, gives viewers a brief update on the status of biosimilars, both in the United States and abroad. He discusses the opposite legal landscapes for biosimilars in the United States and Europe, and offers a prognosis regarding future developments in both markets.

Embed Video